# Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer

> **NCT00417274** · PHASE2 · COMPLETED · sponsor: **Cleveland BioLabs** · enrollment: 31 (actual)

## Conditions studied

- Prostatic Cancer

## Interventions

- **DRUG:** Quinacrine

## Key facts

- **NCT ID:** NCT00417274
- **Lead sponsor:** Cleveland BioLabs
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2013-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00417274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00417274, "Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00417274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*